PT is routinely used to prevent venous and arterial thrombosis in patients at risk due to ischemic heart disease, prosthetic valves, coronary stents, primary prophylaxis of coronary thrombosis, as secondary prevention in adverse thrombo-embolic events in patients with coronary thrombosis history, cerebrovascular accidents as well as unstable angina.
La TAP es usada rutinariamente para la prevención de trombosis arteriales y venosas, en pacientes con condiciones de riesgo como cardiopatía isquémica, válvulas protésicas, stents coronarios, profilaxis primaria de trombosis coronaria y como prevención secundaria en eventos tromboembólicos adversos en pacientes con historia de trombosis coronaria, accidente cerebrovascular y angina inestable.